Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenomethionine with chemotherapy and radiation for rectal cancer
NCT00625183Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Mar 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selenomethionine in rectal adenocarcinoma, sponsored by Roswell Park Comprehensive Cancer Center. Started Mar 2008; status: terminated.
02
Drugs
selenomethionine
03
Conditions
rectal adenocarcinoma
Beyond the preview
Go deeper on NCT00625183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625183.